InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by ROSENWALD LINDSAY A MD, Director. Officer active across 3 companies, notably Checkpoint Therapeutics, Inc.. In total, 8 reports have been recorded. The latest transaction was filed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
047,619 shares0
COMMON STOCK
SEC:0001104659-22-074466:0·
€2,4521,297 shares@ €1.89070.0029% mcap100.0% of flow
COMMON STOCK, PAR VALUE $0.001
SEC:0001104659-22-053615:0·
€2,5561,170 shares@ €2.18450.056% mcap100.0% of flow
COMMON STOCK
SEC:0001104659-21-119389·
€2,5561,170 shares@ €2.18450.056% mcap50.0% of flow
COMMON STOCK
SEC:0001104659-21-119389:0·
013,774 shares0
COMMON STOCK
SEC:0001104659-21-090243·
013,774 shares0
COMMON STOCK
SEC:0001104659-21-090243:0·
016,502 shares0
COMMON STOCK
SEC:0001104659-21-080362:0·
016,502 shares0
COMMON STOCK
SEC:0001104659-21-080362·
8 of 8 declarations
About ROSENWALD LINDSAY A MD
Lindsay A. Rosenwald, MD, is President, CEO, and Chairman at Checkpoint Therapeutics, Inc., Mustang Bio, Inc., and Fortress Biotech, Inc. He is responsible for the strategic and operational direction of these companies, leveraging his expertise in biotechnology to drive innovation and growth.
